EP 2 800 811 B1 relates to methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription.
In § [0005] of the patent it is specified that “Any reference to genetic modification of cells do not encompass the germline modification of human beings.”
In § [0006] of the patent it is specified that “The compositions of the invention do not comprise human germ cells,